Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess whether any relative benefit on overall survival (OS) from the combination of denosumab and standard of care (SOC) versus SOC alone in non-small cell lung cancer (NSCLC) is associated with tumor RANK expression
Inclusion criteria
- non-small cell lung cancer